Global Retirement Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.61M | Buy |
+37,710
| New | +$2.05M | 0.02% | 573 |
|
|
2025
Q4 | $5.96M | Buy |
62,528
+16,821
| +37% | +$1.65M | 0.11% | 183 |
|
|
2025
Q3 | $4.46M | Buy |
45,707
+6,330
| +16% | +$656K | 0.1% | 188 |
|
|
2025
Q2 | $4.23M | Buy |
+39,377
| New | +$3.98M | 0.1% | 182 |
|
|
2024
Q4 | $396K | Buy |
4,439
+69
| +2% | +$6.07K | 0.01% | 712 |
|
|
2024
Q3 | $366K | Buy |
4,370
+449
| +11% | +$35.4K | 0.01% | 727 |
|
|
2024
Q2 | $302K | Buy |
3,921
+2,073
| +112% | +$152K | 0.01% | 740 |
|
|
2024
Q1 | $127K | Buy |
1,848
+739
| +67% | +$47.5K | ﹤0.01% | 977 |
|
|
2023
Q4 | $66.8K | Buy |
1,109
+309
| +39% | +$16.5K | ﹤0.01% | 1228 |
|
|
2023
Q3 | $41.2K | Buy |
800
+4
| +0.5% | +$210 | ﹤0.01% | 1357 |
|
|
2023
Q2 | $43.1K | Sell |
796
-72
| -8% | -$3.76K | ﹤0.01% | 1346 |
|
|
2023
Q1 | $45.7K | Sell |
868
-192
| -18% | -$9.05K | ﹤0.01% | 1284 |
|
|
2022
Q4 | $49K | Sell |
1,060
-1
| -0.1% | -$43 | ﹤0.01% | 1092 |
|
|
2022
Q3 | $46K | Buy |
1,061
+63
| +6% | +$2.53K | ﹤0.01% | 1050 |
|
|
2022
Q2 | $37K | Buy |
998
+76
| +8% | +$3.09K | ﹤0.01% | 1108 |
|
|
2022
Q1 | $37K | Buy |
922
+324
| +54% | +$14K | ﹤0.01% | 1114 |
|
|
2021
Q4 | $25K | Sell |
598
-24
| -4% | -$1.01K | 0.02% | 114 |
|
|
2021
Q3 | $27K | Buy |
622
+15
| +2% | +$664 | ﹤0.01% | 1095 |
|
|
2021
Q2 | $26K | Buy |
607
+15
| +3% | +$631 | ﹤0.01% | 1101 |
|
|
2021
Q1 | $23K | Sell |
592
-181
| -23% | -$6.85K | ﹤0.01% | 1059 |
|
|
2020
Q4 | $28K | Buy |
773
+59
| +8% | +$2.13K | ﹤0.01% | 920 |
|
|
2020
Q3 | $27K | Hold |
714
| – | – | ﹤0.01% | 823 |
|
|
2020
Q2 | $25K | Buy |
714
+306
| +75% | +$11K | ﹤0.01% | 828 |
|
|
2020
Q1 | $13K | Buy |
408
+174
| +74% | +$6.8K | ﹤0.01% | 935 |
|
|
2019
Q4 | $11K | Sell |
234
-104
| -31% | -$4.35K | ﹤0.01% | 1126 |
|
|
2019
Q3 | $14K | Sell |
338
-182
| -35% | -$7.71K | ﹤0.01% | 1024 |
|
|
2019
Q2 | $22K | Sell |
520
-4
| -0.8% | -$154 | ﹤0.01% | 855 |
|
|
2019
Q1 | $20K | Sell |
524
-23
| -4% | -$878 | ﹤0.01% | 820 |
|
|
2018
Q4 | $19K | Sell |
547
-434
| -44% | -$15.7K | ﹤0.01% | 754 |
|
|
2018
Q3 | $38K | Buy |
981
+713
| +266% | +$24.9K | 0.01% | 624 |
|
|
2018
Q2 | $9K | Sell |
268
-99
| -27% | -$2.99K | ﹤0.01% | 1017 |
|
|
2018
Q1 | $10K | Sell |
367
-647
| -64% | -$17.6K | ﹤0.01% | 961 |
|
|
2017
Q4 | $25K | Buy |
1,014
+719
| +244% | +$19.8K | 0.01% | 664 |
|
|
2017
Q3 | $9K | Buy |
295
+41
| +16% | +$1.13K | ﹤0.01% | 857 |
|
|
2017
Q2 | $7K | Buy |
254
+164
| +182% | +$4.35K | ﹤0.01% | 855 |
|
|
2017
Q1 | $2K | Buy |
+90
| New | +$2.19K | ﹤0.01% | 1012 |
|
Other funds holding BSX
Global Retirement Partners's BSX Position: Q2 2026 in Review
Global Retirement Partners opened a new position in Boston Scientific (BSX) in Q2 2026: 37,710 shares worth $1.61M. The stake represents 0.02% of the portfolio and ranks #573 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in BSX as recently as Q4 2025.
Global Retirement Partners first reported a position in BSX in Q1 2017 and has held it in 36 quarters since. The position peaked at $5.96M in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Global Retirement Partners held 37,710 shares of Boston Scientific worth $1.61M as of Q2 2026.
- Boston Scientific was a new Global Retirement Partners position in Q2 2026.
- Boston Scientific made up 0.02% of Global Retirement Partners's portfolio in Q2 2026, its #573 holding.
- Global Retirement Partners first reported a position in Boston Scientific in Q1 2017 and has held it in 36 quarters since.
- Global Retirement Partners's Boston Scientific position peaked at $5.96M in Q4 2025.
- 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.